Investigating how a protein regulates gene expression in Pseudomonas aeruginosa
Global post-transcriptional regulators in P. aeruginosa
This study is looking at how a protein called Hfq helps bacteria, like Pseudomonas aeruginosa, control their genes, which could help us find better ways to treat infections, especially for people with cystic fibrosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Children's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10734761 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a protein called Hfq in the regulation of gene expression in the bacteria Pseudomonas aeruginosa, which is known to cause serious infections, particularly in patients with cystic fibrosis. The study aims to identify the targets of small regulatory RNAs that interact with Hfq and how these interactions affect the bacteria's ability to produce proteins. By examining how Hfq associates with RNA during its synthesis, the research seeks to uncover new insights into bacterial behavior and virulence. This could lead to better strategies for managing infections caused by this pathogen.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cystic fibrosis or those at risk of infections from Pseudomonas aeruginosa.
Not a fit: Patients who do not have infections caused by Pseudomonas aeruginosa or cystic fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for infections caused by Pseudomonas aeruginosa, particularly in vulnerable populations such as cystic fibrosis patients.
How similar studies have performed: Previous research has shown success in understanding bacterial gene regulation, making this approach promising for uncovering new therapeutic targets.
Where this research is happening
Boston, United States
- Boston Children's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Dove, Simon L — Boston Children's Hospital
- Study coordinator: Dove, Simon L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.